BioSpace News Archive

VINIA Subscription Growth Drives 101% Year-over-Year Increase in May Product Sales Orders; Cumulative Customer Reviews Surpass 5,000

FibroBiologics, Inc. announced that Chief Scientific Officer, Hamid Khoja, Ph.D., will present on FibroBiologics’ wound care and psoriasis programs at the Extracellular Matrix (ECM) Pharmacology Congress in Copenhagen, Denmark, from June 17-19, 2024.

Prolific Machines, the photomolecular biology innovator ushering in a new era of biotechnology by growing and controlling cells with light, announces it has closed an initial round of $55M Series B financing, including convertible notes, for a total of $86.5M in funding to date.

PureTech Health plc is pleased to announce that at the General Meeting of the Company held at 11:00 a.m. New York City time at the Company’s offices at 6 Tide Street, Boston, Massachusetts, 02210, United States, the proposed Special Resolution as set out in the Circular containing the Notice of General Meeting circulated to Shareholders and published on 20 May 2024 was duly passed.

SynapCell celebrates today the ten-year anniversary of its partnership with the University of Utah as the prime contract testing site of the National Institute

Anthos Therapeutics, Inc., a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences (BXLS), today provided an update on the transition of patients in the open-label extension (OLE) portion of the AZALEA-TIMI 71 study.

Intelligent Bio Solutions Inc. today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024.

Allergan Aesthetics, an AbbVie company, the makers of BOTOX® Cosmetic, is celebrating 25 years of SkinMedica®.

Ensysce Biosciences, Inc. today announced the achievement of a critical milestone in its opioid use disorder (OUD) program with the selection of a lead drug candidate to move into Investigational New Drug (IND) enabling studies.